SAISON-INFO-SYSTEMS
Saison Information Systems Co., Ltd. (JASDAQ:9640) (Headquarters: Tokyo, Japan; CEO: Kazuhiro Uchida) opened an office in London on July 6, 2017. It will function as an operations base for servicing the EMEA region, with an initial focus on sales of HULFT, the company’s highly successful managed file transfer (MFT) middleware.
Background
After HULFT gained an overwhelmingly dominant share of its segment in the Japanese market, Saison Information Systems has been working to expand its global footprint by establishing overseas subsidiaries and opening offices as follows.
- China: HULFT China Co., Ltd. was established in May 2012 and has offices in Shanghai and Beijing.
- ASEAN: HULFT Pte. Ltd. was established in Apr. 2015 and has an office in Singapore.
- North America: HULFT Inc. was established in Apr. 2016 and has an office in San Mateo, California.
These efforts have born results, and as of the end of March 2017:
- HULFT had 189,600 HULFT licenses in use by 8,700 companies in 43 countries worldwide; and,
- DataSpider Servista had been installed by over 3,000 companies.
The decision was made to set up in the EMEA region to meet the needs of end users and partners there.
Office Details
• Name: Saison Information Systems Co., Ltd. EMEA Office
• Location: 6th Floor, First Central 200, 2 Lakeside Drive, London NW 10 7FQ, United Kingdom
• Establishment: July 6, 2017
• Contact: SalesSupport_EMEA@hulft.com
• Activities: Research, marketing, and liaison with companies located in the EMEA region.
About HULFT
Compatible with an ever-growing range of platforms since its launch in 1993, HULFT is managed file transfer (MFT) middleware equipped with all the functionality enterprises need to share data between business systems. As of March 2017, there are 189,600 HULFT licenses in use by 8,700 companies in 43 countries worldwide, spanning a broad range of industries. In addition to sending, receiving and managing file transfer jobs, HULFT also includes peripheral functions essential to transferring files, including security and integration of data before and after transfer.
Product Details: https://www.hulft.com/en/hulft-mft/
About DataSpider Servista
As of March 2017, DataSpider Servista has been installed by over 3,000 companies. In Japan, it has been ranked No. 1 in customer satisfaction for four years running*. Its GUI enables quick and easy setup without the need for coding. Its many adapters can connect a wide variety of systems, applications, databases, and other data sources hosted either on-premise or in the cloud. It can be used to automate a broad range of processes, thereby greatly improving an organization’s operational efficiency.
Product Details: https://www.hulft.com/en/dataspider-servista/
* Source: EAI Software survey by Nikkei BP Consulting, April 2017.
Saison Information Systems Co., Ltd.
- Headquarters: Sunshine 60 (21F), 3-1-1 Higashi-Ikebukuro, Toshima-ku, Tokyo 170-6021, Japan
- Established: September 1970
- President: Kazuhiro Uchida (President & CEO)
- Website: http://home.saison.co.jp/english/
Notes:
* HULFT and related product names are registered trademarks or trademarks of Saison Information Systems Co., Ltd.
* DataSpider and DataSpider Servista are registered trademarks or trademarks of Appresso K.K.
* Other company names, product names and service names are registered trademarks or trademarks of their respective companies.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170705006158/en/
Contact:
Saison Information Systems Co., Ltd.
Product Inquiries:
Masaaki
Takayama, +81-3-3988-5301
HULFT Division
info@hulft.com
or
Press
Inquiries:
Akane Toyota, +81-3-3988-3477
Corporate Planning
Department
kikaku@saison.co.jp
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CCM Biosciences Announces Presentation of Data on its First-In-Class AML Drug Program at ASCO 202520.5.2025 22:30:00 CEST | Press release
Company’s AML drug program is focused on both newly diagnosed and relapsed/refractory FLT3-positive AML, overcoming major forms of resistance to FDA-approved FLT3 inhibitors, and outperforms other investigational inhibitors in a wide range of drug resistance models. CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its next-generation FLT3 inhibitor drug program for acute myeloid leukemia (AML) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. Acute Myeloid Leukemia (AML) is the most severe form of leukemia with few treatment options, and a malignancy frequently driven by mutations in the FMS-like tyrosine kinase 3 (FLT3) gene. The FLT3 internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations, particularly D835 and F691, appear in approximately 30% of AML patients, often leading to poor prognosis and resistance to exi
IonQ Partners with Sweden’s Einride to Develop Quantum Supply Chain and Quantum-Enhanced Logistics for Autonomous Driving Solutions20.5.2025 22:05:00 CEST | Press release
IonQ and Einride will collaborate to develop quantum solutions for fleet routing, logistics optimization, and supply chain solutionsIonQ’s investment will grow its European presence and reinforce commitment to building a quantum economy in Sweden and the European market IonQ (NYSE: IONQ), a leading commercial quantum computing and networking company, today announced an investment partnership with Einride, a leading global freight mobility company that provides digital, electric, and autonomous technology to explore how quantum computing can drive the next generation of fleet optimization and logistics. Together, IonQ and Einride will develop quantum applications that address large-scale routing and scheduling problems that have traditionally challenged classical computing. By combining IonQ’s advanced quantum systems with Einride’s expertise in autonomous fleet logistics, the two companies will work to unlock new levels of efficiency, reliability, and sustainability for the global frei
CCM Biosciences Announces Presentation of Data on its First-In-Class NSCLC Drug Program at ASCO 202520.5.2025 21:26:00 CEST | Press release
Company’s NSCLC drug program is focused on overcoming both mutational and non-mutational resistance to 3rd-generation EGFR inhibitors and outperforms other investigational 4th-generation inhibitors in a wide range of drug resistance models. CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its 4th-generation EGFR inhibitor drug program for non-small cell lung cancer (NSCLC) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. NSCLC, which accounts for 80% of lung cancer, is the most common cause of cancer death worldwide. Epidermal growth factor receptor (EGFR)-activating mutations (Del19 or L858R) are major oncogenic drivers of NSCLC. EGFR-positive NSCLC accounts for approximately 30% of all diagnosed cases of NSCLC (a similar market size to PD-L1-positive NSCLC, which is addressed by the world’s top-selling drug, Keytruda®). The current s
NielsenIQ's Chief Technology Officer Mohit Kapoor Named Executive of the Year at Global Tech & AI Awards for Leading NIQ’s AI-Driven Tech Transformation20.5.2025 21:24:00 CEST | Press release
NielsenIQ (NIQ) is proud to announce that Mohit Kapoor, Chief Technology Officer, was named Executive of the Year at the inaugural Global Tech & AI Awards. This honor recognizes Mohit's exceptional leadership and visionary contributions to the tech industry, particularly in the realm of AI-powered consumer intelligence. "I am deeply honored to receive the Executive of the Year award at the Global Tech & AI Awards. This recognition is a testament to the incredible work and dedication of the entire NielsenIQ team,” said Mohit Kapoor, Chief Technology Officer, NIQ. “Together, we have redefined consumer and retail intelligence, leveraging AI to deliver unparalleled insights and drive meaningful change in the industry." Under Mohit's leadership, NIQ has adopted an AI-powered approach to its ambitious digital transformation which included a $400 million technology investment and the migration of its global client base onto Discover– a unified, cloud-based platform that seamlessly integrates
Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco20.5.2025 21:08:00 CEST | Press release
As part of the implementation of the commitments made in the joint declaration between His Majesty King Mohammed VI, may God Assist Him, and His Highness Sheikh Mohamed bin Zayed Al Nahyan, TAQA Morocco, in partnership with Nareva and the Mohammed VI Fund for Investment, has signed three memorandums of understanding and related development agreements with the Government of Morocco and ONEE. These agreements cover the development of structuring projects in the power, water and renewable energy sectors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250520313620/en/ Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco (Photo: AETOSWire) The program aims to strengthen the Kingdom's water and energy sovereignty through the development of flexible natural gas-based power generation capacit
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom